 [125][126][127][128] 
Chronic idiopathic thrombocytopenic purpura (ITP) is a rare disease, developing in a minority of children with ITP, but its management is fraught with worry and controversy. Numerous reviews and the large number of therapeutic approaches attest to uncertainty about the most effective and safe treatment and highlight the lack of knowledge about its natural history. Standard diagnostic criteria, comprising isolated thrombocytopenia with a history of purpura and absence of other causes, were used. Chronic ITP was defined as thrombocytopenia (platelet count < 150X 1 09/) persisting more than six months after initial diagnosis of ITP. Recovery was defined as absence of purpura or abnormal bruising together with a persistently normal platelet count.
Incidence was calculated from the more recent, demographically defined, data set using population estimates from the Office of Population Censuses and Surveys and the Northern Regional Health Authority.
Rates of spontaneous recovery and response to splenectomy from the combined data sets were related to the duration of symptoms before initial presentation. 
, perhaps more insidious, period of bruising is not statistically significant (p=0'2 1).
DEATHS
Three of the deaths in the first data set have already been reported,6 and the lack of direct relevance of chronic ITP itself emphasised8; one died of drowning several years after a spontaneous remission, one in a road traffic accident, and one from pneumococcal sepsis after splenectomy. One further patient is known to have died of a malignant thalamic astrocytoma more than 20 years after his original presentation. In the second data set one boy, whose chronic ITP developed after Hodgkin's disease, died from an intracranial haemorrhage after a physical assault to his head. No unprovoked haemorrhagic death, solely attributable to chronic ITP, has occurred in either group. The single septic death occurred before the risks of postsplenectomy sepsis were known. Since regular penicillin prophylaxis and, later, immunisation against pneumococcal infection have been employed, no case of postsplenectomy sepsis has occurred but too few splenectomies have been carried out for meaningful analysis.
EFFECTS OF TREATMENT OTHER THAN SPLENECTOMY
Prednisone was used at some stage of the disease at least as frequently (in 25 of 26 cases) in the more recent group as in the earlier cases (21 of 66), for whom it was available after 1962. In the more recent group 10 children were prescribed several or prolonged courses of prednisone. Spontaneous recovery occurred promptly in one and improvement in another on stopping it. There is no suggestion that steroid treatment was of more than temporary benefit. Azathioprine, interferon alfa, and vitamin C were used without benefit in one child each. Intravenous IgG infusions were used in nine of the 26 recent cases but induced remission in none. From the point of diagnosis of chronic ITP (six months after initial presentation) 14 children from the recent group received no specific treatment. Lack of intervention may even have been beneficial as nine of the 11 spontaneous remissions thus far observed in the second data set occurred in these 14 children.
Discussion
This study, which combines recently diagnosed cases with those in the previous report,6 is essentially retrospective. It will probably have missed occasional cases, most likely some mildly affected children who had spontaneous remissions or adolescents not referred to a paediatric haematologist. None the less, these 92 children comprise the largest study of chronic ITP in children to have been reported, and for some purposes it is reasonable to amalgamate the two groups of children. Attempts to illustrate in detail, and over the entire time course during which the cases arose, the likely outcome in all those remaining at risk of spontaneous remission are hampered by the fact that several cases from the first data set have been lost to follow up and by lack of knowledge about the precise timing of remission in some. Despite these problems, the predicted spontaneous remission rate in the 85 children for whom there are reasonable data is 61% after 15 years, and in total 39 children are known to have had a spontaneous remission. Thus this study's major importance lies in confirmation of the high spontaneous remission rate suggested in several small studies9-12 but it also documents the low mortality and fails to show long term benefit from active treatment other than splenectomy.
Few reports of rTP in children focus on chronic disease, partly due to its rarity. the fact that the study was restricted to the experience of a single centre precludes calculations of incidence from their data. Despite this, their rate of accrual (2-2 cases per year over 30 years) is only slightly below that (2 6 per year) of the second, population based data set. If this calculated incidence is correct and has not altered over time, approximately 12 cases of chronic ITP within the region were missed in their series. The combined groups of patients probably represent close to 90% of all childhood chronic ITP arising during 40 years within the Northern health region.
Walker and Walker's observation of a link between duration of presenting symptoms and eventual outcome has remained useful in the general approach to newly presenting children with ITP,6 but its potential relevance to the management of chronic ITP, as it is now defined, was not examined. Reanalysis of their data, when combined with the observed outcome of more recently diagnosed cases, shows that children with a short initial history who develop chronic disease have a significantly greater chance of remitting after splenectomy than those with longer histories. Potential bias due to selected referral of more severe cases in the earlier group could be a confounding influence if those more mildly affected cases who recovered spontaneously (and were not referred) were more likely to have had prolonged initial histories. This is implausible. It is possible, however, that adult physicians and general haematologists only rarely referred adolescents with chronic ITP to paediatricians in the 1 950s and 1 960s. Their behaviour would not have been documented. There is also a trend towards increased chance of spontaneous remission in those with short histories. This trend, however, is too weak at present to be clinically valuable and should in any case be interpreted with caution because some children who remitted after splenectomy (and not included in the crudely defined group at risk of spontaneous remission) did not have their operation until more than one year after initial presentation. The two week cut off in duration of presenting symptoms is arbitrary, as is the current definition of chronicity, but there may be underlying biological differences between those with a sudden and others with an insidious onset of ITP. This study was not designed to investigate that possibility nor to look for a more meaningful definition of chronic ITP. Whatever the biological implications, the link between duration of presenting symptoms and outcome of splenectomy in those who develop chronic ITP may be at least as useful as platelet sequestration studies,13 as yet not adequately evaluated in children, when assessing the potential role of splenectomy in an individual child.
Of the five deaths, two were accidental and one from an unrelated tumour. Two children would probably not have died had they not had chronic ITP but death was a direct complication of splenectomy in one and the result of a physical assault in another. It will need a study at least an order of magnitude greater than the 40 years' accumulated experience of chronic ITP from this region accurately to estimate its mortality and to distinguish iatrogenic influences from those of the disease itself. No case can be made from these data that splenectomy can reduce the risk of death.
Decisions about splenectomy are unique to each case and involve many factors, some unquantifiable, which affect the child's quality of life and the extent of the disability. They are also influenced by the perceived risks of the procedure. Splenectomy's fall from favour, a result of growing awareness of these risks, was suggested in the earlier report.6 It was carried out only half as frequently in the more recent group. It is possible that its frequency in the earlier group was artificially high because of central referral of more serious cases. The similarity in rates of accrual in the two groups suggests that a selection effect, if present, was not great. The data in this report support recently expressed opinions24 14 that splenectomy should not be entered into hurriedly and may contribute to further decline in its popularity.
Despite the wide range of possible therapeutic approaches, vinca alkaloids, anti-D, and danazol have not been favoured in this region. Interferon alfa and azathioprine are rarely employed. Some paediatricians/haematologists use more prednisone and intravenous IgG than others, and appear to prefer repeated or prolonged courses of either than to accept modest or fluctuating thrombocytopenia, but without detectable long term benefit. In one case splenectomy was preferable to steroid induced hypertension. Improvement in at least two children in the more recent group directly followed cessation of steroid treatment, a pattern observed previously by Walker and Walker.6 However, all those cases were treated before management guidelines were published. 4 Data from this study concerning the incidence, outcome, and trends in management of chronic ITP will supplement the copious published opinions. Natural history remains less clear because most children received some form of treatment, even if only within the first six months after first presenting with ITP. However, many children from both groups have been followed up for long periods, once chronic ITP was established, without specific treatment. Their behaviour is likely to be as close to the natural history of this disease as it will be possible to observe. This study has shown that chronic ITP in children has a very low mortality, that splenectomy was the only active treatment to result in long term benefit and that the overall outcome, whether a reflection of natural history or the result of therapeutic intervention, is generally benign. Should splenectomy need to be seriously considered in an individual child, the length of presenting symptoms may influence the decision. This report should encourage those who wish to pursue a relatively non-interventionist plan of management in individual children. However, it does not help to identify the very rare child with chronic ITP who will have an unprovoked intracranial haemorrhage, not least because such a catastrophe has not yet been observed in the Northern health region.
